Analogic (ALOG) Upgraded by BidaskClub to Sell

BidaskClub upgraded shares of Analogic (NASDAQ:ALOG) from a strong sell rating to a sell rating in a report released on Friday.

A number of other brokerages also recently issued reports on ALOG. Zacks Investment Research downgraded Analogic from a buy rating to a hold rating in a research report on Wednesday, January 31st. Jefferies Group restated a hold rating and set a $80.00 price objective on shares of Analogic in a research report on Friday, December 8th.

How to Become a New Pot Stock Millionaire

Shares of ALOG opened at $95.90 on Friday. Analogic has a 1 year low of $66.00 and a 1 year high of $101.80. The stock has a market cap of $1,198.85, a PE ratio of 55.76, a P/E/G ratio of 3.24 and a beta of 0.77.

Analogic (NASDAQ:ALOG) last issued its quarterly earnings data on Monday, March 5th. The medical research company reported $1.27 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.69 by $0.58. Analogic had a positive return on equity of 6.05% and a negative net margin of 15.34%. The company had revenue of $129.20 million during the quarter, compared to the consensus estimate of $112.50 million. During the same period last year, the company earned $0.99 earnings per share. The firm’s revenue was down 1.7% compared to the same quarter last year. research analysts predict that Analogic will post 4.23 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 26th. Stockholders of record on Thursday, March 15th were given a dividend of $0.10 per share. The ex-dividend date was Wednesday, March 14th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.42%. Analogic’s dividend payout ratio (DPR) is 23.26%.

Several institutional investors and hedge funds have recently modified their holdings of ALOG. Acadian Asset Management LLC bought a new stake in Analogic in the fourth quarter worth approximately $3,102,000. Bank of Montreal Can increased its holdings in Analogic by 37.6% in the fourth quarter. Bank of Montreal Can now owns 52,237 shares of the medical research company’s stock worth $4,375,000 after purchasing an additional 14,280 shares in the last quarter. Bogle Investment Management L P DE bought a new stake in Analogic in the fourth quarter worth approximately $3,095,000. BlackRock Inc. increased its holdings in Analogic by 2.8% in the fourth quarter. BlackRock Inc. now owns 1,656,666 shares of the medical research company’s stock worth $138,746,000 after purchasing an additional 44,707 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its holdings in Analogic by 10.6% in the third quarter. Ameriprise Financial Inc. now owns 354,655 shares of the medical research company’s stock worth $29,703,000 after purchasing an additional 34,021 shares in the last quarter. Institutional investors own 97.58% of the company’s stock.

WARNING: This piece of content was reported by WKRB News and is owned by of WKRB News. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at https://www.wkrb13.com/2018/04/02/analogic-alog-upgraded-by-bidaskclub-to-sell.html.

Analogic Company Profile

Analogic Corporation designs, manufactures, and sells medical imaging systems, ultrasound and security systems, and subsystems to original equipment manufacturers (OEMs) and end users primarily for the medical and airport security markets worldwide. It operates in three segments: Medical Imaging, Ultrasound, and Security and Detection.

Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply